文献速递妇科肿瘤

术前淋巴细胞与单核细胞比值与卵巢上皮癌临床病理特征及预后的关系

[The relationship of preoperativelymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2017-01-01

该研究回顾性分析2005—2011年哈尔滨医科大学附属肿瘤医院364例初治卵巢上皮癌患者资料,以ROC曲线确定术前LMR预测术后生存的最佳截点为3.84,并据此分组分析。结果显示术前LMR与术后FIGO分期、腹水及CA125水平有关,低LMR组中位PFS和OS均显著短于高LMR组,Cox多因素分析表明LMR≤3.84是PFS和OS的独立危险因素,术前LMR可用于评估卵巢上皮癌患者预后。

要点

  • 术前LMR预测卵巢上皮癌术后生存的最佳截点为3.84。
  • 低LMR组中位PFS 56个月 vs 高LMR组88个月(P<0.01)。
  • LMR≤3.84是卵巢上皮癌PFS和OS的独立危险因素(P<0.05)。

核心结论

  • 术前LMR是影响卵巢上皮癌患者PFS和OS的独立因素,可用来评估卵巢上皮癌患者的预后。

研究设计与样本

  • 回顾性分析2005—2011年间哈尔滨医科大学附属肿瘤医院收治的364例初治卵巢上皮癌患者的临床资料。
  • 通过建立受试者工作特征曲线确定术前外周血LMR预测患者术后生存的最佳截点值,以最佳截点值将患者分为低LMR组和高LMR组。
  • 中位随访时间为37个月。

主要发现

  • 术前LMR与患者的术后FIGO分期、有无腹水、CA125水平有关(均P<0.05)。
  • 低LMR组与高LMR组患者的中位PFS分别为56和88个月,差异有统计学意义(P<0.01)。
  • 低LMR组与高LMR组患者的中位OS分别为69和100个月,差异有统计学意义(P<0.01)。
  • 单因素分析显示,术后FIGO分期、病理分级、有无腹水、有无淋巴结转移、CA125水平、有无辅助治疗、术前LMR与术后PFS有关(均P<0.05)。
  • 单因素分析显示,年龄、术后FIGO分期、病理分级、有无腹水、有无淋巴结转移、CA125水平、有无辅助治疗、术前LMR与术后OS有关(均P<0.05)。

关键数值与推荐

  • LMR预测卵巢上皮癌患者术后生存的最佳截点值为3.84。
  • Cox多因素分析显示,术后FIGO分期为Ⅲ~Ⅳ期、肿瘤分级为低分化、伴有淋巴结转移、术后无辅助治疗和LMR≤3.84是影响卵巢上皮癌患者PFS和OS的独立危险因素(均P<0.05)。

临床怎么用

  • 术前LMR可作为评估卵巢上皮癌患者预后的指标,LMR≤3.84提示预后较差。

局限性

  • 原文未述局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the relationship of preoperative lymphocyte-monocyte ratio (LMR) and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer (EOC). Methods: Clinical data of 364 cases of EOC patients with initial treatment were collected in Harbin Medical University Cancer Hospital from 2005-2011 and analyzed retrospectively.The optimal cut-off points of preoperative LMR to predict the postoperative survival period of EOC patients were determined by the establishment of receiver operating characteristic (ROC) curve. The patients were divided into low LMR group and high LMR group according to the optimal cut-off points, and the relationship of LMR and the clinicopathological factors and prognosis of EOC patients were analyzed. Results: The best cut-off point of preoperative LMR to predict the postoperative survival period of EOC patients was 3.84. The preoperative LMR of EOC patients was significantly associated with the postoperative FIGO stage, ascites and CA125 level (all P<0.05). The median follow-up time was 37 months, the median progression-free survival (PFS) time of low LMR group was 56 months, significantly shorter than 88 months of high LMR group (P<0.01). And the median overall survival (OS) time of low LMR group was 69 months, significantly shorter than 100 months of high LMR group (P<0.01). The univariate analysis showed that the postoperative FIGO stage, pathological grade, ascites, lymph node metastasis, CA125 level, adjuvant therapy, preoperative LMR were all significantly associated with PFS (all P<0.05). In addition, the age, postoperative FIGO stage, pathological grade, ascites, lymph node metastasis, CA125 level, adjuvant therapy, preoperative LMR were all significantly associated with OS (all P<0.05). Cox multivariate analysis showed that postoperative FIGO stage Ⅲ-Ⅳ, low differentiation, positive lymph node metastasis, without postoperative adjuvant therapy and LMR≤3.84were independent risk factors of PFS and OS of EOC patients (P<0.05). Conclusion: The preoperative LMR is an independent influence factor of PFS and OS of EOC patients, and can be used to evaluate the prognosis of patients with EOC. 目的: 探讨术前淋巴细胞与单核细胞比值(LMR)与卵巢上皮癌患者的临床病理特征和预后的关系。 方法: 回顾性分析2005—2011年间哈尔滨医科大学附属肿瘤医院收治的364例初治卵巢上皮癌患者的临床资料,通过建立受试者工作特征曲线,确定术前外周血LMR预测患者术后生存的最佳截点值,以最佳截点值将患者分为低LMR组和高LMR组,分析LMR与患者的临床病理因素和预后的关系。 结果: LMR预测卵巢上皮癌患者术后生存的最佳截点值为3.84。卵巢上皮癌患者的术前LMR与患者的术后国际妇产科联盟(FIGO)分期、有无腹水、糖类抗原125(CA125)水平有关(均P<0.05)。中位随访时间为37个月,低LMR组与高LMR组患者的中位无进展生存时间(PFS)分别为56和88个月,差异有统计学意义(P<0.01);低LMR组与高LMR组患者的中位总生存时间(OS)分别为69和100个月,差异有统计学意义(P<0.01)。单因素分析显示,卵巢上皮癌患者的术后FIGO分期、病理分级、有无腹水、有无淋巴结转移、CA125水平、有无辅助治疗、术前LMR与术后PFS有关(均P<0.05);卵巢上皮癌患者的年龄、术后FIGO分期、病理分级、有无腹水、有无淋巴结转移、CA125水平、有无辅助治疗、术前LMR与术后OS有关(均P<0.05)。Cox多因素分析结果显示,术后FIGO分期为Ⅲ~Ⅳ期、肿瘤分级为低分化、伴有淋巴结转移、术后无辅助治疗和LMR≤3.84是影响卵巢上皮癌患者PFS和OS的独立危险因素(均P<0.05)。 结论: 术前LMR是影响卵巢上皮癌患者PFS和OS的独立因素,可用来评估卵巢上皮癌患者的预后。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Yang HM, Lou G. [The relationship of preoperativelymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer]. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 28926896. doi:10.3760/cma.j.issn.0253-3766.2017.09.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。